Matthew HerperForbes August 19, 2011 The Food and Drug Administration approved Adcentris, from Seattle Genetics, to treat Hodkin lymphoma and anaplastic large cell lymphoma. It is the first new treatment for Hodgkin lymphoma in 34 years. The FDA’s press release can be found here. The drug was granted accelerated approval, meaning that additional studies […]